Biodesix Files 8-K on Shareholder Votes and Financials
Ticker: BDSX · Form: 8-K · Filed: May 23, 2024 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-governance, financial-reporting
TL;DR
Biodesix filed an 8-K on May 23rd covering shareholder votes and financials as of May 21st.
AI Summary
Biodesix, Inc. filed an 8-K on May 23, 2024, reporting on matters submitted to a vote of security holders and financial statements and exhibits. The filing covers events as of May 21, 2024. The company is incorporated in Delaware and its principal executive office is located in Louisville, Colorado.
Why It Matters
This filing provides updates on corporate governance matters and financial reporting, which are crucial for investors to understand the company's operational and financial status.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- May 21, 2024 — Date of earliest event reported (This is the date as of which the reported events occurred.)
- May 23, 2024 — Date of Report (This is the date the 8-K filing was made.)
Key Players & Entities
- Biodesix, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Louisville, Colorado (location) — Principal Executive Office
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in this excerpt.
What financial statements and exhibits are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in this excerpt.
What is Biodesix, Inc.'s principal executive office address?
Biodesix, Inc.'s principal executive office is located at 919 West Dillon Rd., Louisville, Colorado 80027.
In which state was Biodesix, Inc. incorporated?
Biodesix, Inc. was incorporated in Delaware.
What is the SIC code for Biodesix, Inc.?
The Standard Industrial Classification (SIC) code for Biodesix, Inc. is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Stats: 911 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-05-23 16:10:06
Key Financial Figures
- $0.001 — registered Common Stock, par value of $0.001 per share BDSX The Nasdaq Stock Mar
Filing Documents
- d832577d8k.htm (8-K) — 42KB
- 0001193125-24-145965.txt ( ) — 162KB
- bdsx-20240521.xsd (EX-101.SCH) — 3KB
- bdsx-20240521_lab.xml (EX-101.LAB) — 18KB
- bdsx-20240521_pre.xml (EX-101.PRE) — 11KB
- d832577d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIODESIX, INC. Dated: May 23, 2024 By: /s/ Robin Harper Cowie Name: Robin Harper Cowie Title: Chief Financial Officer